The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...
As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...
By Michael Erman and Deena Beasley Jan 27 (Reuters) - The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead Sciences' HIV drug ...
FDA fast tracks ADHD drug centanafadine, targeting approval by July 24 for treatment across all age groups, based on phase 3 trial results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results